MAPT and Alzheimer disease: Considering all plasma and serum biomarkers, t-Tau is the only that discriminates patients with AD from controls in most of the studies performed [5] showing a minor increase in plasma Tau in AD patients, although with too large overlap with controls to be diagnostically useful [19].